Liljana Spidle, PA
Medical · Glen Ridge, NJNPI 1174561146
Payments from drug & device makers
Across 111 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$411
- AbbVie$304
- Gilead$216
- Ardelyx, Inc.$120
- GSK$112
- Exact Sciences$101
- plus $703 from 18 others
What the payments were for
- Food & beverage$1,88296%
- Education$854%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 22 | $411 |
| AbbVie | 22 | $304 |
| Gilead | 12 | $216 |
| Ardelyx, Inc. | 1 | $120 |
| GSK | 8 | $112 |
| Exact Sciences | 4 | $101 |
| Janssen Products, LP | 1 | $85 |
| Lilly USA, LLC | 5 | $76 |
| Merck | 5 | $71 |
| Amarin Pharma, Inc. | 4 | $58 |
| Johnson & Johnson | 3 | $50 |
| Vifor Pharma, Inc. | 3 | $50 |
| Amgen | 3 | $48 |
| Viiv Healthcare Company | 3 | $44 |
| Pfizer | 3 | $44 |
| Boston Scientific | 2 | $31 |
| AstraZeneca | 2 | $30 |
| Daiichi Sankyo Inc. | 2 | $27 |
| Corcept Therapeutics | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| Phadia US Inc. | 1 | $15 |
| Dynavax Technologies Corporation | 1 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,967 in reported general payments places this provider in the 75th percentile of 573 medical providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 116 | $131,671 |
| JanuviaSitagliptin Phosphate | 62 | $66,104 |
| JardianceEmpagliflozin | 47 | $44,558 |
| FarxigaDapagliflozin Propanediol | 30 | $32,854 |
| EliquisApixaban | 18 | $23,285 |
| RybelsusSemaglutide | 11 | $20,158 |
| MounjaroTirzepatide | 16 | $17,020 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $14,913 |
| LinzessLinaclotide | 13 | $13,541 |
| TradjentaLinagliptin | 13 | $11,898 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $8,564 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 15 | $6,739 |
| Diclofenac Sodium | 62 | $5,580 |
| Atorvastatin Calcium | 234 | $2,530 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $2,306 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $411 | $151,829127 claims |
| MerckJanuvia, Janumet Xr | $71 | $72,84277 claims |
| AstraZenecaFarxiga, Symbicort | $30 | $35,16041 claims |
| PfizerEliquis | $44 | $23,28518 claims |
| Lilly USA, LLCMounjaro | $76 | $17,02016 claims |
| GSKTrelegy Ellipta | $112 | $14,91323 claims |
| AbbVieLinzess | $304 | $13,54113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 573 medical providers in New Jersey.
Other medical in Glen Ridge
- Alison PietrasBrick$1.2M
- Shannon WelnerVerona$176K
- Christinna DelgenioColts Neck$114K
- Anita FoxVerona$17K
- Therese CasasKinnelon$16K
- Joseph CollettiLinwood$16K
- Melissa MiaoKearny$14K
- Gabriela Plesek-AndiaVerona$13K
- Stephanie PhillipsMarlton$12K
- Sean AdairCape May Court House$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.